ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate UpdateGlobeNewsWire • Thursday
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIOPRNewsWire • 04/10/24
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIOBusiness Wire • 04/05/24
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with OrukaPRNewsWire • 04/03/24
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to ShareholdersBusiness Wire • 04/03/24
ARCA biopharma Announces 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 02/24/23
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options ReviewGlobeNewsWire • 05/05/22
ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical TrialGlobeNewsWire • 03/31/22
ARCA biopharma Announces 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire • 03/14/22
Data on Gencaro Impact on Prevention of Bradycardia Published in Heart Rhythm O2GlobeNewsWire • 01/04/22